Alzamend Neuro News

Latest Alzamend Neuro Stock News & ALZN Headlines

Alzamend Neuro (ALZN) Upgraded to Buy: What Does It Mean for the Stock?

a month ago | zacks.com

Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending

3 months ago | prnewswire.com

Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital

7 months ago | prnewswire.com

Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions

8 months ago | prnewswire.com

Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital

8 months ago | prnewswire.com

Alzamend Neuro (NASDAQ:ALZN) Stock Price Down 2.5% – Should You Sell?

10 months ago | defenseworld.net

Alzamend Neuro (NASDAQ:ALZN) Stock Price Down 0.5% – Here’s Why

a year ago | defenseworld.net

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

a year ago | prnewswire.com

Alzamend Neuro to Present at the 2025 Military Health System Research Symposium

a year ago | globenewswire.com

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

a year ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

ALZN

Alzamend Neuro

$ 1.24

-4.62%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Alzamend Neuro News

Latest Alzamend Neuro Stock News & ALZN Headlines

Download App

People Also Watch

Explore our Tools